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To understand the molecular basis of a phosphoryl transfer reaction
catalyzed by the 6-phosphofructo-2-kinase domain of the hypoxia-inducible
bifunctional enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3), the crystal structures of PFKFB3 AMPPCP fructose-6phosphate and PFKFB3 ADP phosphoenolpyruvate complexes were determined to 2.7 Å and 2.25 Å resolution, respectively. Kinetic studies on the
wild-type and site-directed mutant proteins were carried out to confirm
the structural observations. The experimentally varied liganding states in
the active pocket cause no significant conformational changes. In the
pseudo-substrate complex, a strong direct interaction between AMPPCP
and fructose-6-phosphate (Fru-6-P) is found. By virtue of this direct
substrate–substrate interaction, Fru-6-P is aligned with AMPPCP in an
orientation and proximity most suitable for a direct transfer of the γphosphate moiety to 2-OH of Fru-6-P. The three key atoms involved in the
phosphoryl transfer, the β,γ-phosphate bridge oxygen atom, the γphosphorus atom, and the 2-OH group are positioned in a single line,
suggesting a direct phosphoryl transfer without formation of a phosphoenzyme intermediate. In addition, the distance between 2-OH and γphosphorus allows the γ-phosphate oxygen atoms to serve as a general
base catalyst to induce an “associative” phosphoryl transfer mechanism.
The site-directed mutant study and inhibition kinetics suggest that this
reaction will be catalyzed most efficiently by the protein when the
substrates bind to the active pocket in an ordered manner in which ATP
binds first.
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Introduction
Every mammalian cell is equipped with one of
the four distinct gene-encoded tissue isoforms of

Abbreviations used: PFKFB, 6-phosphofructo-2-kinase/
fructose-2,6-bisphophatase; 2-Kase, 6-phosphofructo-2kinase; 2-Pase, fructose-2,6-bisphophatase; Fru-6-P,
fructose-6-phosphate; Fru-2,6-P2, fructose-2,6bisphophate; PEP, phosphoenolpyruvate; AMPPCP,
β,γ-methylene-adenosine 5′-triphosphate; GntK,
gluconate kinase.
E-mail address of the corresponding author:
yhlee@lsu.edu

the bifunctional enzyme 6-phosphofructo-2-kinase/
fructose-2,6-bisphosphatase (PFKFB): liver, PFKFB1;
heart, PFKFB2; testis, PFKFB4; and inducible forms,
PFKFB3.1–4 The PFKFB tissue isoforms optimize
glucose utilization in a tissue-specific manner. Although these isoforms share a high level of sequence
identity in the core catalytic domains (> 85%), each
isoform has different kinetic properties and responds differently to upstream regulatory signals.
This molecular differentiation results from the
highly divergent N and C-terminal regulatory domains and the sequence differences in the second
shell residues surrounding the active site pockets of
the catalytic domains.5–7 Unlike the other three
isoforms, PFKFB3 is expressed ubiquitously upon
the onset of hypoxic stress and found to be identical
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with the forms isolated from placenta, pancreatic
beta-cell, and brain.8–12
PFKFB controls the cellular concentration of
fructose-2,6-bisphosphate (Fru-2,6-P2) by modulating the two mutually opposing catalytic activities of
Fru-2,6-P2 synthesis (2-Kase, 6-phosphofructo-2kinase) and hydrolysis (2-Pase, fructose-2,6-bisphosphatase), which reside in a single protein molecule
as two separate domains.1,2,13 Fru-2,6-P2 is the most
potent allosteric activator of phosphofructokinase,
the rate-limiting enzyme of glycolysis, and the
inhibitor of fructose-1,6-bisphosphatase, the ratelimiting enzyme of gluconeogenesis.1,2,13 As such,
changes in the Fru-2,6-P2 concentrations by PFKFB
cause changes in the glycolytic rates in all tissues,
and both glycolysis and gluconeogenesis in liver.
Ultimately, PFKFB controls cellular glycolysis and
gluconeogenesis to optimize glucose utilization in a
tissue-specific manner. To carry out this function, the
two catalytic activities in PFKFB are exquisitely
regulated by various metabolic products and signal
transduction-dependent phosphorylation, such that
the resulting predominant activity determines the
final concentration of Fru-2,6-P2 and, ultimately, the
rates of glycolysis in all tissues, and both glycolysis
and gluconeogenesis in the liver.1,2,13
Due to its biological significance and the complexity of regulation of PFKFB isoforms, and their potential applicability to medicine, the PFKFB enzyme
system has long been a focus of structure/function
studies. As a result, the structures of PFKFB1 and
PFKFB4 have become available and, thus, an understanding of a molecular differentiation of the PFKFB
isoforms has been reached.6,7 Structure/function
studies using the separate 2-Pase domain allowed
understanding of the reaction mechanism of 2-Pase
at the molecular level.14,15 However, despite long,
continuous efforts, understanding of the 2-Kase
reaction at a molecular level has been lacking.
Although significant progress was made using
PFKFB4, no detailed information on catalytic
mechanism has been available to date except for
the locations of substrate-binding sites and a few
catalytic site residues.7,16 This slow progress is
largely due to the insufficient molecular level
information on the interactions made by Fru-6-P in
the 2-Kase active pocket. No attempt to achieve
2-Kase Fru-6-P complex has been successful to date.
We have studied the PFKFB enzyme system and
made significant contributions to understanding the
structure/function relationships of this enzyme
system at the molecular level. As part of our
continued efforts to understand the differences
between the PFKFB isoforms at the molecular level,
we recently determined the crystal structures of the
human tumor/inducible form of 6-phosphofructo2-kinase/fructose-2,6-bisphosphatase (PFKFB3) in a
near native state (PFKFB3 ADP EDTA, PDB accession code 2AXN) and its product complex of PFKFB3
ADP Fru-2,6-P2 (PDB accession code 2DWP).5
It has been suggested that PFKFB isoforms are
involved in metabolic disorders, including diabetes,
obesity, and cancer. High levels of blood glucose are

U

U

U U

U

related to low concentrations of hepatic Fru-2,6-P2
and can be ameliorated by activation of 2-Kase
activity of PFKFB1. The high 2-Kase activity of
PFKFB3 is considered as a driving force of cancer
glycolysis. A small molecule that can inhibit PFKFB3
2-Kase may serve as a new cancer drug. Thus,
understanding of 2-Kase catalytic mechanism at
the molecular level is urgent for drug development.
To study the unknown molecular catalytic mechanism of 2-Kase, we determined the structure of the
PFKFB Fru-6-P complex in the presence of the nonreactive ATP-analogue AMPPCP (β,γ-methyleneadenosine 5′-triphosphate), employing the PFKFB3
isoform, and that of an inhibitory complex of
PFKFB3 ADP PEP (phosphoenolpyruvate). These
structures were compared with that of the previously attained PFKFB3 ADP Fru-2,6-P2 complex.
Although the structure of this product complex was
introduced originally to confirm the location of the
active pocket,5 its functional details have not been
reported. Thus, the functionality of this product
complex is discussed here, together with new studes
on the catalytic mechanism of the kinase reaction.
The results of structure/function studies are discussed here.
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Results and Discussions
Overall structure
As shown in the ribbon diagram of a single subunit
of PFKFB3 complexed with ADP and PEP, PFKFB3
has two separate catalytic domains (Figure 1(a)). As
in the PFKFB3 ADP EDTA complex, the N-terminal
residues 4–15 of both complexes form a β-hairpin
structure to make contacts with the C-terminal 2Pase domain at the area where the residues involved
in binding the 6-phosphate moieties of both substrate and product are collectively located. In this
way, the self-regulatory effect by the N terminus on
the 2-Pase activity is not affected by the N-terminal 2Kase liganding.5 Even Fru-6-P binding to the 2-Kase
active pocket does not involve any conformational
change in the N terminus, in contrast to a previous
suggestion based on a fluorescence study.17 The structures of the C terminus (residues 446–520) remain
disordered,5 despite the varied liganding states of
the 2-Kase.
Possible conformational changes in the 2-Kase
core domain by the experimentally varied liganding
conditions were investigated by superposition of the
structures. The structures of the PFKFB3 AMPPCP
Fru-6-P complex and the PFKFB3 ADP PEP complex were superposed onto that of the PFKFB3 ADP
Fru-2,6-P2, using least-squares error transformations
of the Cα positions. The resulting superposed structures of the 2-Kase domains are shown in Figure 1(b).
No residue diverged by more than 0.5 Å, except for
those forming the ATP loop (residues 168–179) and the
F-6-P loop (residues 72–84). Relatively large differences in the ATP and Fru-6-P loops seem to be caused
by variations in molecular sizes of the ligands bound
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Figure 1. Overall folding of PFKFB3 and ligand binding. (a) A ribbon diagram of monomeric PFKFB3 is shown to
represent the overall folding of the protein. ADP is bound to the 2-Kase (red) active pocket and Fru-6-P to the 2-Pase
(blue). The N-terminal regulatory domain is shown in green. Unless specifically mentioned, all structure Figures were
made using MolScript v2.1.2,45 and rendered using Raster3D v2.7.46 (b) A comparison of 2-Kase fold in different liganding
states. The folding patterns are represented by a tracing of Cα atoms (residues 34–246): PFKFB3 AMPPCP Fru-6-P in
green, PFKFB3 ADP Fru-2,6-P2 in blue, and PFKFB3 ADP PEP in magenta. The ATP site and the Fru-6-P site are
represented by the ball-and-stick models of ADP and Fru-2,6-P2.
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Figure 2. Binding of AMPPCP and Fru-6-P to the 2-Kase catalytic pocket. (a) A stereo view of the |Fo|–|Fc| omit
electron density map from the PFKFB3 AMPPCP Fru-6-P complex. The map is calculated in the absence of ligands and
contoured around the γ-phosphate moiety of AMPPCP and Fru-6-P at 2.5σ levels. The incorporated ligand structure is
from the final model. The electron density maps are drawn using BobScript v1.4b. (b) Coordination of Mg2+ is shown and
the relative position of Fru-6-P is provided. (c) A stereo view of the binding of Fru-6-P to the 2-Kase catalytic pocket. For
convenient comparison, Fru-2,6-P2 and the interacting residues are drawn in light grey after superposition of the
structures of PFKFB3 AMPPCP Fru-6-P and PFKFB3 ADP Fru-2,6-P2 complexes. (d) The direct interactions between
AMPPCP and Fru-6-P in the 2-Kase active site pocket. The dotted lines represent hydrogen bonds or salt-bridges. The
interactions between the γ-phosphate moiety of AMPPCP and the protein are shown. ATP bound to PFKFB1 in the
absence of Mg2+ is superposed to show the importance of Mg2+. A grey dotted line is drawn between the bridge oxygen
atom in ATP and O2 of Fru-6-P to emphasize the in-line positioning of the two oxygen and the γ-phosphorus atoms.
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Figure 2 (legend on previous page)

to the Fru-6-P site. However, the extents are not
comparable to those of substrate-induced conformational changes observed in PFKFB4 (the testis
isoform),16 or in other similarly folded small molecule
phosphoryl transferases.18–21 The shikimate, the
gluconate, and the nucleoside monophosphate
kinases undergo a conformational shift between the
“closed” and “open” states, depending on binding of
substrates or products. In PFKFB4, the last turn of the
α5 switch helix (residues 158–171) of the ATP loop
undergoes unwinding upon displacing ADP with
ATP. This unwinding allows a key catalytic residue,
Lys168, to interact with the bridge oxygen atom of β
and γ-phosphate groups of ATP, otherwise pointing to
the surface.16 A conformational change similar to

PFKFB4 has been observed from the c-ras protein.20
This switch motion has been hypothesized to induce
a conformation necessary for the subsequent binding of Fru-6-P, a mechanism for ordered binding
of the two substrates in the case of PFKFB4. However, this helix is always unwound, regardless of
ADP or ATP binding, and the critical catalytic interaction made by Lys168 is always present in PFKFB1
and in PFKFB3, due to their sequence-based structural differences from PFKFB4.5,6
Binding of substrates and products
In previous trials to achieve a Fru-6-P complex
using ATPγS as an ATP analogue, the reaction
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proceeded and resulted in the PFKFB3 ADP Fru2,6-P2 product complex.5 To abolish this unwanted
reaction, non-reactive β,γ-methylene-adenosine 5′triphosphate (AMPPCP) was used in the current
study. A resulting |Fo|–|Fc| omit map generated
from the PFKFB3 AMPPCP Fru-6-P complex in the
absence of ligands revealed electron densities
representing AMPPCP, a Mg2+, and Fru-6-P (Figure
2(a)). The position of Mg2+ was confirmed by its coordination in addition to the electron density (Figure
2(b)). In this structure, the Mg2+ is coordinated by
two phosphate oxygen atoms from AMPPCP, three
solvent molecules, and OG1 of Thr48 with distances in a range of 2.2–3.0 Å, forming an octahedral coordination.
As compared in Figure 2(c), Fru-6-P occupies the
same binding site as Fru-2,6-P2 in the PFKFB3
ADP Fru-2,6-P2 complex, which is embedded in this
Figure.5 The substrate (Fru-6-P) and the product
(Fru-2,6-P2) share a number of residues for binding.
These interactions are summarized in Table 2. This
positional overlap suggests that Fru-6-P in the
PFKFB3 AMPPCP Fru-6-P complex binds to the
catalytic site, and that this complex indeed mimics
the reactive ternary substrate complex. Fru-6-P
binds to the active pocket through its 6-phosphate
moiety, which interacts with Arg98, Thr126, Arg132,
and Tyr193 as Fru-2,6-P2 does, but in a manner
slightly different from that of Fru-2,6-P2. Tyr193 is
omitted from the Figure to enhance visual clarity.
The interactions made by Arg74 with O3 and O4,
and by Arg189 with O1, and by Tyr193 with O5
appear critically important for a phosphoryl transfer
catalyzed by this enzyme. By virtue of these hydrogen bonds, O1 and O2 of the furanosyl ring of Fru-6P are oriented by the γ-phosphate group of ATP
(Figure 2(d)). Moreover, the interaction between O1
and Arg189 serves to select only β-anomeric Fru-6-P
as substrate, as demonstrated in an NMR study of
PFKFB1.22
Similar to Fru-6-P, major interactions of Fru-2,6-P2
with the protein occur through its 6-phosphate
moiety. A significant difference from Fru-6-P is that
only O3 interacts with Arg74 and O4 with Arg98
instead of Arg74. This difference is caused by the
added phosphate at the O2 position as the result of
the phosphoryl transfer reaction catalyzed by this
protein. The 2-phosphate does not have any significant interaction with the protein, except for with
Lys168. But, as will be described later, Lys168 remains in the same position regardless of the liganding states of the protein. Because of the negative
charges in the β-phosphate moiety of ADP and the
2-phosphate of Fru-2,6-P2, the two products repel
each other. To minimize this repulsive force, it
appears that the 2-phosphate rotates downward to
the entrance to the catalytic pocket after completion
of the phosphoryl transfer. There, 2-phosphate has a
total of four hydrogen bonds with the neighboring
solvent molecules (data not shown) that are located
at near the entrance to the catalytic pocket. This implies that 2-phosphate has more chances to interact
with water molecules from the bulk solvent. Even-
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tually, it will lead to solvation of 2-phosphate and
may help the release of Fru-2,6-P2 from the active
pocket upon completion of a catalytic cycle.
Surprisingly, no additional amino acid residue is
employed for the interactions with the γ-phosphate
moiety of AMPPCP (Figure 2(d)). Although Lys168
and Lys47 are positioned at distances of 2.9 Å from
the γ-phosphate to provide salt-bridges, the conformations of Lys168 and Lys47, which also provide salt-bridges to the β-phosphate in other
ADP complexes, are not changed significantly from
those in other ADP complexes. It appears that the
γ-phosphate oxygen atoms are simply inserted into
the bonding field of the two positively charged
residues. Lys47 is a member of the Walker A motif,
consisting of –41GLPARGKT48–, which is shared in
all PFKFB isoforms.7 The previous functional study
showed that site-directed mutagenesis of Lys47
causes a decrease in kcat by an order of magnitude,
suggesting its critical role in catalysis.23 Its dual
interactions with both the β and γ-phosphate
suggest that Lys47 may be involved in stabilization
of the transition state. Functional characterization of
Lys168 was done previously,24 and its critical role in
catalysis is confirmed here. The detailed description
of this study is given in the following section.
Notably, the position of Lys168 is not affected even
when the residue is exposed to the β and γphosphate-bridging carbon atom in AMPPCP
instead of an oxygen atom in ADP or ATP. This is
probably because of the added interaction with the
γ-phosphate oxygen atoms. The unvaried conformation of Lys168 may be facilitated by its hydrophobic
intercalation between Val167 and Phe186 (data not
shown).
Co-liganded with AMPPCP, Mg2+ provides two
salt-bridges to the two oxygen atoms, O2B and O2G,
from the β and γ-phosphate moieties of AMPPCP
with distances of 2.6 Å and 2.4 Å, respectively, as
pointed out earlier (Figure 2(b)). Providing interactions with the phosphate oxygen atoms, Mg2+ also
seems to have an important role in the 2-Kasecatalyzed phosphoryl transfer. As shown in Figure
2(d), Mg2+ makes a major contribution to orientation of the γ-phosphate suitable for an in-line phosphoryl transfer. The γ-phosphate group of ATP
complexed with PFKFB1 in the absence of Mg2+
(PDB accession code 1K6M),23 which is embedded,
is located in a position different from that in
the presence of Mg2+, explaining why this protein
family requires Mg2+ for its catalytic reaction. The
γ-phosphate group of ATPγS complexed with
PFKFB4 in the presence of Mg2+ (PDB accession
code 1BIF)23 shares the same position as that in the
current ternary PFKFB3 AMPPCP Fru-6-P complex,
supporting the function of Mg2+ suggested here.
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Direct substrate–substrate interaction
As described above, the γ-phosphate group of
AMPPCP has only modest interactions with the
protein. However, it was found that this phosphate
moiety mediates a strong direct substrate–substrate
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Table 1. Statistics of reflection data and structure
refinements

U

U

PFKFB3 AMPPCP
Fru-6-P

Liganding
Space group
Unit cell dimensions
a = b (Å)
c (Å)
Resolution range (Å)
No. reflections used
Completeness (%)
Redundancy
I/σ(I)
Rsym
Rcrys
Rfree
No. amino acids
No. protein atoms
No. hetero atoms
No. water molecules
r.m.s.d. from ideal
Bond lengths (Å)
Bond angles (deg.)
Dihedral angles (deg.)
Mean Bfactor
Protein atoms (Å2)
Hetero atoms (Å2)
Water atoms (Å2)

U U

PFKFB3 ADP
PEP

P6522

P6522

101.99
258.07
30.0–2.7
21,941
96.4 (64.8)
9.8 (4.0)
16.2 (1.6)
0.135 (0.473)
0.224
0.264
433
3520
64
296

102.29
258.62
30.0–2.25
38,937
99.7 (99.1)
7.0 (4.2)
26.2 (3.7)
0.054 (0.334)
0.214
0.243
449
3657
52
298

0.006
1.2
21.9

0.009
1.4
22.1

56.5
53.1
53.1

40.0
37.9
51.2

Rsym = ∑h(∑|
j Ih,j–<Ih>|/∑Ih,j), where h = set of Miller indices,
j = set of observations of reflection h, and <Ih>=the mean
intensity. Rcrys = ∑h||Fo,h|–|Fc,h|
|/∑h|Fo,h|. Rfree was calculated using 10% of the complete data set excluded from
refinement. The numbers in parentheses represent values from
the highest resolution shell (2.75–2.70 Å).
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interaction between AMPPCP and Fru-6-P in the
PFKFB3 AMPPCP Fru-6-P structure, as shown in
Figure 2(d). In this complex, all three γ-phosphate
oxygen atoms make direct interactions with O1 and
O2 of Fru-6-P. The O3G and O2G form hydrogen
bonds with O2 of Fru-6-P, the phosphoryl acceptor,
with distances of 2.8 Å and 2.9 Å, respectively. And
O1G interacts with O1 at a distance of 2.7 Å. As a
consequence of this strong direct interaction, the
distance between AMPPCP and Fru-6-P in the
pseudo-substrate complex is 0.4 Å shorter than that
between ADP and Fru-6-P2 in the product complex.
This interligand interaction may also have caused a
21°-rotated position of the furanose ring of Fru-6-P
and a different position of O1 of Fru-6-P relative to
Fru-2,6-P2. The resulting torsional strain may have
caused differences between Fru-6-P and Fru-2,6-P2
in their interactions through the 6-phosphate
moieties (Figure 2(c)).
The direct interaction between AMPPCP and Fru6-P provides an interesting insight into the phosphoryl transfer mechanism catalyzed by 6-phosphofructo-2-kinase of the PFKFB protein family. In
addition to the hydrogen bonds made between
the furanosyl oxygen atoms and the protein, a direct intersubstrate interaction between O1 and O2
and the γ-phosphate causes O2 of Fru-6-P to locate
nearest to the γ-phosphorus atom. In the current
PFKFB3 AMPPCP Fru-6-P structure, the phosphoryl acceptor, O2 of Fru-6-P, is located only
3.1 Å away from the γ-phosphorus of AMPPCP.
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O2 is the most closely located non-covalent atom
from γ-phosphorus and, as a result, can serve as the
most efficient acceptor of the γ-phosphate from ATP.
Furthermore, O2, the γ-phosphorus, and the β and
γ-phosphate bridge oxygen atoms are located on a
near a single line with a measured angle of 164°, as
indicated by a grey dotted line in Figure 2(d). The
distance between the phosphoryl acceptor and
the γ-phosphorus, and the geometric arrangement
of the three atoms together suggest an “in-line”
transfer of phosphate accompanied with inversion
of phosphorus configuration.25,26 This structural
observation coincides with the previous biophysical
observation on the stereochemical course of phosphoryl transfer catalyzed by PFKFB1.22 When the
configuration of transferred phosphorus atom was
tested by 31P NMR spectroscopy, using [γ-(S)-16O,
17
O, 18O]ATP as probing substrate, an in-line transfer with a net inversion of configuration was
observed. From this observation, a double displacement ping-pong mechanism was suggested, and
formation of a covalent phosphoenzyme intermediate was ruled out. A similar conclusion suggesting
an in-line sequential mechanism was made from an
isotope exchange reaction study performed by a
different group.27 The three independent studies
together suggest that PFKFB 2-Kase reaction follows
an in-line phosphoryl transfer.
In the current structure, the distance between the
phosphoryl donor, the bridge oxygen atom, and
the acceptor, O2 of Fru-6-P, is 4.8 Å. If the estimated
coordinate error of 0.42 Å is added, this distance is
still within 5.22 Å. This geometry suggests that the
in-line transfer is likely to follow an associative
mechanism26–29 in which O2 of Fru-6-P functions as
the attacking nucleophile. For O2 to function as a
nucleophile, a base catalyst that deprotonates –OH
to form an active nucleophile, has to be located
within hydrogen bond distance. From a search for
Table 2. Interactions of the Fru-6-P site-bound ligands
with the protein and ATP
Protein atoms
Lys47
Arg74
Arg75
Arg98
Thr126
Arg132
Lys168
Arg189
Tyr193
*ATP

NZ
NE
NH2
NH1
NH2
NE
NH1
NH2
N
OG1
NH1
NZ
NE
NH2
OH
O1G
O2G
O3G

Fru-6-P
O3 (2.8)
O4 (3.1)

Fru-2,6-P2

O3 (2.7)

PEP
O2 (2.6)
O2 (3.0)

EDTA
O5 (2.8)
O4 (2.7)
O2 (2.6)
O7 (3.1)
O8 (3.0)

O3P (2.7)
O2P (3.2)
O6 (2.4)
O6P (2.1)
O5P (3.0)
O1 (3.4)
O6 (2.7)
O5 (3.5)
O1 (2.7)
O2 (2.9)
O2 (2.8)

O4P (3.1)
O6 (3.1)
O6P (2.6)
O5P (2.5)
O1P (3.2)
O1 (3.2)
O1 (2.9)
O4P (2.6)
O5 (3.5)

O1P (3.5)
O2P (2.8)

O4 (3.2)
O6 (2.9)
O3 (3.2)

O1 (3.8)
O2P (2.6)

*ATP: atoms from the PFKFB3+bound AMPPCP. Numbers in
parentheses are distances (in Å).
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such a base catalyst, a water molecule that is
hydrogen-bonded to Asn69 and involved in coordination of Mg2+ was found 3.1 Å away from O2
(Figure 2(c)). This water molecule may be able
to serve as a base catalyst if activated by a Lewis
acid function of Mg2+,30 and/or by Asn69. Divalent
cations other than Mg2+ usually slow the reaction but
do not abolish reactivity.30 A previous site-directed
mutagenesis study suggested that Asn69 does not
have a significant role in catalysis.31 Both observations diminish the functional value of this water
molecule as a base catalyst. On the other hand, as
described above, the γ-phosphate of AMPPCP with
multiple negative charges forms a direct and
stronger interaction to O2. The electron-rich γphosphate that is located within 3 Å may have a
stronger potential than Mg2+-coordinated water in
deprotonating 2-OH of Fru-6-P, or in functioning as a
base catalyst. Moreover, such substrate-assisted
mechanism has been observed from the studies of
Rab11 (a small GTP-binding protein) and GntK
(gluconate kinase).19,32 Since PFKFB 2-Kase folding
is very similar to these proteins with the folding
similarity Z score of 13.8. from the DALI server†
calculation, its catalytic mechanism is likely similar
to theirs. Taken together, we suggest that the
nucleophile formation in PFKFB 2-Kase is performed
by a substrate-assisted mechanism.
Interaction of the β,;-phosphate bridge oxygen
atom with protein
As pointed out above, Lys168 is positioned to
interact with the β,γ-phosphate bridge oxygen
(carbon in AMPPCP) atom, and the main-chain N
of Ala44 is located approximately 3.0 Å away from
the bridge oxygen atom, the phosphoryl donor
(Figure 2(d)). Their locations suggest that they have
an important role in the catalytic mechanism. To test
this possibility, we engineered and kinetically
characterized a total of five site-directed mutant
proteins: Lys168→A, Lys168→N, and Lys168→R
and Ala44→G and Ala44→V. Because the mainchain N of Ala44 interacts with the bridge oxygen, it
is reasonable to consider that varying the size of the
side chain of this residue is accompanied by varied
strengths/distances of the interaction between N
and the bridging oxygen. Since the side-chain of this
residue makes hydrophobic interactions with a local
hydrophobic pocket formed by Val160, Ile164, and
Ile190 (data not shown), addition of a small
hydrophobic side-chain does not cause any significant folding problem. Circular dichroism spectroscopy was used to test all mutants for proper
folding. As summarized in Table 3, changes in this
distance introduced by mutagenesis cause significant changes only in K m for substrates. The
accompanying changes in kcat are insignificant and
less than 20%. The Km values for ATP and Fru-6-P of
Ala44→G are decreased by approximately 20-fold
† http://www.ebi.ac.uk/dali/fssp/

Table 3. Kinetic properties of site-directed mutants
Mutant
Wild-type
Ala44→G
Ala44→V
Lys168→R
Lys168→A or N

kcat (s− 1)

KmATP (μM)

KmF-6-P (μM)

0.14 ± 0.0034
0.19 ± 0.0027
0.17 ± 0.0057
< 0.0003
N.D.

16.9 ± 1.7
0.87 ± 0.09
140.2 ± 2.1
N.D.
N.D.

10.2 ± 2.2
3.8 ± 0.62
204 ± 22.2
N.D.
N.D.

N.D. not determinable.

and threefold, respectively, and those of Ala44→V
are increased by eightfold and 20-fold, respectively.
As such, kinetic observation of the Ala44 mutants
suggests that the main-chain N of Ala44 is involved
mainly in ATP binding rather than catalytic turnover. However, it is notable that changes in Km for
ATP are accompanied by changes in Km for Fru-6-P,
supporting the direct ATP/Fru-6-P interaction.
On the other hand, mutagenesis of Lys168 caused
a complete abolition of the catalytic activity, except
for Lys168→R, which retains only 0.2% of that of the
wild type, confirming previous observations.24 It is
evident that Lys168 has a crucial role in the
phosphoryl transfer reaction. This rationale suggests
a similarity to a function of the “arginine finger”
provided by GAP (GTPase-activating protein) to the
GTPase activity of ras-like small Gα proteins in the
ras GAP complex.20,33,34 This arginine provides a
salt-bridge to the bridge oxygen atom of GTP bound
to the ras protein, which otherwise does not exist.
The arginine residue inserted into the ras active
pocket functions as the transition state stabilizer to
cause an increase in the GTPase activity in an order
of magnitude.33 Similar observations on the positively charged residues interacting with the bridge
oxygen atom have been made from the shikimate
kinase and the gluconate kinase.19,35 The positional
similarity between Lys168 and these residues
suggests that Lys168 also functions as the transition
state stabilizer. Supporting this rationale, Lys168
also interacts with the γ-phosphate oxygen atom,
with a distance of 2.4 Å. This observation suggests
that Lys168, together with Lys47, is involved in
stabilization of the pentavalent phosphorane, which
is transiently formed immediately after the nucleophilic attack of O2 of Fru-6-P on the γ-phosphorus of
ATP. Consequently, mutagenesis of Lys168 results in
a severely compromised catalytic mechanism and
may explain the complete loss of 2-Kase activities of
the Lys168 mutant proteins.
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Suggested catalytic mechanism
On the basis of the structure/function studies, a
possible molecular catalytic mechanism is summarized as follows. A nucleophile is produced by deprotonation of 2-OH of Fru-6-P by the negatively
charged γ-phosphate oxygen atoms. Its nucleophilic attack on the γ-phosphorus initiates the
reaction and is followed by formation of a transient high-energy pentavalent phosphorane. For
the reaction to proceed, negative charges developed on the three equatorial oxygen atoms of the
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phosphorane must be stabilized by Lys168, Lys47,
and Mg2+. The proton extracted from 2-OH by the
γ-phosphate may be involved in stabilization of
this intermediate. Finally, the diester bond
between the bridge oxygen and the γ-phosphorus
is broken by redistribution of the electrons of the
equatorial oxygen atoms. A possible back attack
by the leaving group, ADP, is prevented by
concomitant protonation of the bridge oxygen.
This mechanism is summarized in Figure 3. This
mechanism is quite similar to those adopted by a
number of small-molecule phosphoryl transferases,
including gluconate kinase (GntK),19 and the raslike small GTP-binding protein Rab11.32 Rab11
and GntK share a “substrate-assisted” mechanism
in which the nucleophile is formed as the result of
direct substrate–substrate interactions. As in PFKFB,
Mg2+ has a role in aligning the γ-phosphate in-line
with respect to the phosphoryl acceptor in GntK.
PEP inhibition and substrate-binding order
Phosphoenolpyruvate (PEP) has been suggested
as an allosteric inhibitor of PFKFB3.36 Phosphoryla-

21
tion of Ser460 by protein kinase A or AMPdependent protein kinase causes a conformational
change such that the PEP allosteric inhibition is
alleviated to increase the activity. To find this
intriguing allosteric site and to understand the
molecular mechanism of regulatory phosphorylation of PFKFB3, we determined the structure of
PFKFB3 PEP complex. As shown in a |Fo|–|Fc|
omit map, PEP binding was very obvious (Figure
4(a)) but surprisingly located at the Fru-6-P site in
the active pocket (Figure 4(b)). There, the phosphate
moiety of PEP is almost completely overlapping
with that of the 6-phosphate moiety of Fru-6-P or
Fru-2,6-P2. The unexpected positioning of PEP
suggests strongly that PEP functions as a competitive inhibitor against Fru-6-P, rather than as an
allosteric inhibitor. This positioning is consistent
with the observation from a very early functional
study on PFKFB1 that suggested PEP serves as a
competitive inhibitor.37 Inhibition kinetic studies of
PEP were carried out to confirm this structural
observation. As clearly shown in a double-reciprocal
plot (Figure 5), PEP behaves like a competitive inhibitor against Fru-6-P with apparent Kis of 8.3( ± 0.9)

U

Figure 3. A cartoon of the suggested catalytic pathway. In the clockwise direction, 2-OH of Fru-6-P is deprotonated by
the γ-phosphate moiety of ATP and a nucleophilic attack occurs. An intermediate pentavalent phosphorane is formed,
and the negative charges generated on the planary oxygen atoms are stabilized by Lys47, Lys168, and Mg2+, and maybe a
H+ extracted from 2-OH. Redistribution of the phosphorane electrons breaks a diester bond between the bridge oxygen
and γ-phosphorus atoms. The leaving group is stabilized by a H+. Eventually, the leaving group (ADP) is stabilized
through a salt-bridge to Lys168 to finish the reaction.
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Figure 4. PEP binding to PFKFB3. (a) The |Fo|–|Fc| omit electron density map. The map is calculated in the
absence of ligands and contoured at 2.5σ. (b) A stereo view of the interactions of PEP with the 2-Kase active site pocket is
shown. The dotted lines represent hydrogen bonds or salt-bridges. To show its position in the 2-Kase active pocket, the
structure of PFKFB3 AMPPCP Fru-6-P complex is superposed and Fru-6-P (light gray) is shown.
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μM (Table 4). Thus, the structure and function
studies indicated unequivocally that PEP is a competitive inhibitor.
As described earlier, mutagenesis of Ala44
showed that Fru-6-P binding is sensitive to that of
ATP, a clue to suggest “ordered” binding of substrates. This contradicts our previous speculation
that substrates bind to PFKFB3 in a random manner.
This was based on the absence of a switch motion
and that Arg181, that causes structural coupling of

the two substrate loops in PFKFB4, is Cys in
PFKFB3.5 To investigate this ambiguity, inhibition
kinetics was carried out using a product (ADP) and
a substrate analogue (PEP) as inhibitors. Since using
the other product, Fru-2,6-P2, as an inhibitor is not
suitable in the current 2-Kase assay system, PEP,
which is redefined as a competitive inhibitor of Fru6-P as described above, was adopted as a Fru-6-P
analogue in the inhibition kinetics. As shown in the
double-reciprocal plots in Figure 5 (and see Table 4),

Figure 5. 2-Kase inhibition by ADP and PEP. Double-reciprocal plots were generated in which numbers by the lines
represent inhibitor concentration (μM). (a) Inhibition by PEP with ATP as the variable substrate; (b) inhibition by PEP with
Fru-6-P; (c) inhibition by ADP with ATP; (d) inhibition by ADP with Fru-6-P. Data were fit to one of three equations in
Materials and Methods. The lines represent the calculated lines after fitting the data to the appropriate equation.
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Table 4. ADP and PEP inhibition properties
Variable
Fixed
Inhibitor substrate substrate
PEP
ADP

ATP
Fru-6-P
ATP
Fru-6-P

Fru-6-P
ATP
Fru-6-P
ATP

Kis (μM)
8.3 ± 0.9
17.7 ± 2.5
26.1 ± 8.2

Kii (μM)

Inhibition

89.5 ± 9.8

UC
C
C
NC

127 ± 23

Inhibition: UC, uncompetitive; C, competitive; NC, non-competitive.

a reaction product, ADP behaves as a competitive
inhibitor against ATP (Kis = 17.7( ± 2.5) μM) and a
non-competitive inhibitor against Fru-6-P with
apparent Kis and Kii of 26.1( ± 8.2) μM and 127( ± 23)
μM, respectively. Meanwhile, PEP functions as an
uncompetitive inhibitor against ATP with an apparent Kii of 89.5( ± 9.8) μM in addition to its competitive
inhibition against Fru-6-P, which is described above.
Properties of the current inhibition kinetics suggest
ordered binding of the two substrates with ATP first
as in PFKFB4. 16
Unlike PFKFB4 that undergoes the switch helix
unwinding upon ATP binding, the current PFKFB3
structures suggest no significant ligand-dependent
conformational changes that can be attributable to
the structural basis of ordered binding. Thus, an
explanation for the ordered substrate binding to
PFKFB3 can be made by either of the following or a
combination of both: A change in the protein
conformation associated with binding of substrates
may be too transient to be captured by the
traditional crystallographic method we use. Or, the
order may be related to the potent substratesubstrate interaction between O1 and O2 of Fru-6P and the oxygen atoms of the γ-phosphate group of
ATP. Assuming that the two substrates share a
common entry route to the active site pocket, there is
a possibility that a random binding of one substrate
will cause a severe steric hindrance to binding of the
other substrate. From this viewpoint, PFKFB1,
which was previously assumed to follow random
binding from a simple structural observation, needs
further functional characterization.
Conclusion
To study the molecular basis of the phosphoryl
transfer reaction catalyzed by the 6-phosphofructo2-kinase domain of the bifunctional enzyme
PFKFB1-4, the first crystal structure of a PFKFB
isoform in a ternary substrate complex with Fru-6-P
and ATP-analogue was determined, and a set of
kinetic studies was carried out on the wild-type and
several site-directed mutant proteins. To elucidate
the molecular basis of the catalytic mechanism,
the structure was compared with that of the protein
in ternary product complex with Fru-2,6-P2 and
ADP. A direct substrate–substrate interaction
through the γ-phosphate moiety of ATP and O1
and O2 of Fru-6-P, and the resulting geometry
suggests an in-line phosphoryl transfer initiated by
a substrate-assisted mechanism. It suggests also

that the γ-phosphate of moiety ATP is likely to be
transferred to O2 of Fru-6-P in an associative
manner, with Lys168 playing a critical functional
role. With no significant change in protein conformation, the reaction still follows a sequential
ordered binding of substrates with ATP first. The
observations made from this study are mostly in
agreement with a number of previous functional
studies that were performed on different PFKFB
isoforms. This, together with the fact that constellations of the catalytic site residues in the active
pocket are conserved among all PFKFB isoforms,
suggests that the molecular catalytic mechanism
derived from this study is applicable to all other
PFKFB isoforms. This study has provided a molecular basis of a physiologically important phosphoryl transfer reaction. Accordingly, this study
may contribute to future development of PFKFB1
2-Kase activators and PFKFB3 2-Kase inhibitors,
which may serve as potential therapeutics for diabetes and cancer, respectively. This study also
enhances our understanding of differences in the
structure/function relationships between the PFKFB
isoforms at the molecular level.

Materials and Methods
2-Kase assay and kinetic analysis
To determine steady-state initial reaction rates, the 2Kase reactions were performed first and the F-2,6-P2
produced was measured according to the conventional
method.38 The 2-Kase reaction mixture (final volume of
0.2 ml) contained 20 mM Tris–HCl (pH 8.5), 3 mM DTT,
0.5 mM MgCl2, and the indicated amounts of ATP, ADP,
PEP, and Fru-6-P. The reaction was started by adding
the mutant or wild-type enzyme and incubation at 25 °C
for 20 min, and the concentration of Fru-2,6-P2 was
determined every 5 min. Fru-2,6-P2 was measured spectrophotometrically at 340 nm using the potato pyrophosphate-dependent 6-phosphofructokinase (PPi -PF1K)
activation assay within 1 h of stopping the reaction by
the addition of 125 mM NaOH. The PPi-PF1K reaction
mixture contained ( final volume of 1 ml in a disposable
cuvette) 50 mM Tris–HCl (pH 8.5), 5 mM MgCl2, 0.1 mM
NADH, 5 mM DTT, 1 mM Fru-6-P, 0.45 U (unit of enzyme
activity) of aldolase, 0.6 U of glycerol-3-phosphate
dehydrogenase, 1.8 U of triosephosphate isomerase and
10 mU of PP i-PF1K. The accessory enzymes were
purchased from Roche (Indianapolis, IN). PPi-PF1K was
either from Sigma or purified from a potato tuber
according to the conventional method.38 The purified
PPi-PF1K in 40% (v/v) glycerol with protease inhibitors
(E64 and Pepstatin from Roche) stored at −20 °C maintained its activity for longer than 1 month. The reaction
was started by adding 0.5 mM sodium pyrophosphate.
Initial rates of decrease in absorbance at 340 nm were
corrected for the rate of the control reaction in which no
Fru-2,6-P2 was present.
The initial velocities were fitted to one of the following
equations ((1), competitive; (2), noncompetitive; (3),
uncompetitive inhibition) by the program reported by
Cleland,39 in which Kis and Kii are the dissociation
constants for the inhibitor from E S and E S I complexes,
respectively. V is the maximal velocity, A is the substrate
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concentration, I is the inhibitor concentration, and K is the
Michaelis–Menten constant.
VA

v¼ 
K 1 þ KIis þ A

ð1Þ

VA



v¼ 
K 1 þ KIis þ A 1 þ KIii

ð2Þ

VA


v¼
K þ A 1 þ KIii

ð3Þ

Preparation and crystallization of PFKFB3 and the
mutant proteins
Site-directed mutagenesis of 2-Kase was made using
QuickChange PCR (Stratagene, La Jolla, CA) according to
the manufacturer's protocol and confirmed by DNA
sequencing. The oligonucleotides for mutagenic PCR
were synthesized from Invitrogen (Carlsbad, CA). Other
procedures of DNA manipulation were according to
conventional standard methods. The mutant proteins
were over-expressed and purified by the methods used
for the wild-type.5 Preparation of the protein sample and
its crystallization was performed as described.5 The His6tagged human inducible bifunctional enzyme was
expressed in Escherichia coli BL21(DE3)pLysS and purified
using Ni-NTA affinity columns and the N-terminal His6
tag was removed by treatment with thrombin using a
standard protocol. The final purification was performed
using Mono Q anion-exchange chromatography and the
resulting pure protein was kept, after concentrating to
8 mg ml− 1 protein, in 20 mM Tris–HCl (pH 8.0), 10 mM
NaPi, 0.05 mM EDTA, 5 mM β-mercaptoethanol, 0.2 mM
ADP, 5% glycerol, 0.2 mM Fru-6-P. Crystals were
prepared by the sitting-drop, vapor-diffusion method
with a 1:1 (v/v) mixture of the protein sample with a
reservoir solution of 50 mM Tris–HCl (pH 7.5), 20–25%
ethylene glycol, 12% (v/v) dioxane, 5% glycerol, and 12%
(w/v) polyethylene glycol 4000. Crystals with a size of
0.2 mm × 0.4 mm × 0.5 mm grew in two to three weeks.
Diffraction data collection and processing
Crystals were soaked with cryoprotectant solutions for
0.5 to 2 h to allow binding of the targeted ligands before
cryogenic data collections.5 Depending on the experimental aims, cryoprotectant solutions (a crystallization reservoir solution enriched with 35% ethylene glycol) were
enriched with either 0.2 mM AMPPCP Mg2+ and Fru-6-P,
or PEP. Both the complexes of PFKFB3 AMPPCP Fru-6-P
and PFKFB3 ADP PEP were obtained by soaking the
PFKFB3 native crystals with solutions containing the target
ligands. A soaked crystal was flash-frozen at 100 K using
an Oxford cryo-device and kept at the same temperature
during data collections. The diffraction data were collected
at The Gulf Coast Consortium Protein Crystallography
Beamline (PX1) in The Center for Advanced Microstructures and Devices (CAMD), Louisiana State University,
Baton Rouge, LA. The X-ray source wavelength was
1.3808 Å. The data recorded on a Mar 165 mm CCD
detector were integrated, merged, and scaled using
HKL2000.40 Statistics of the diffraction data and structure
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refinement are summarized in Table 1. The crystals belong
to space group P6522 with similar cell dimensions varied
insignificantly by the experimental liganding conditions.
Structure determination and refinement
The reduced data were formatted for the program suites
of CCP441 and CNS,42 and 10% of the data were marked
for free R-factor measurements in subsequent structure
refinements. To ensure a freedom to structural refinements, the indices of reflections in the free data were kept
as those of the structure of the PFKFB3 ADP EDTA
complex (PDB accession code 2AXN).5 The structures of
the two different complexes of PFKFB3 AMPPCP Fru-6P and PFKFB3 ADP PEP were determined by molecular
replacement using the first PFKFB3 structure (PDB
accession code 2AXN)5 as the starting model after
stripping all the included ligand and solvent molecules.
The molecular replacement solutions were readily
achieved using AMoRE43 implemented in the CCP4
suite.41 The initial model went through iterated cycles of
manual model rebuilding using the program O,44 and
refinement using CNS.42 Binding of the included ligands
was confirmed, referring to the|Fo|–|Fc|omit maps that
were generated, when Rcrys/Rfree reached 0.28/0.30 or
below. Referring to these maps, AMPPCP, Mg2+, Fru-6-P,
or PEP was incorporated into the corresponding complex
models. As summarized in Table 1, the final model of the
PFKFB3 AMPPCP Fru-6-P complex has Rfree/Rcrys of
0.264/0.224 using a total of 3880 scatterers, including
solvent molecules, against all available 21,941 reflections
in the resolution range of 30.0–2.7 Å. Because of the limited
resolution, only the group B-factor refinement was
performed for this structure. The structure contains a
total of 433 amino acid residues of the full-length protein
of 520 residues. As in the PFKFB3 ADP EDTA complex,5
the C terminus (residues 446–520) is mostly disordered.
The structure of the PFKFB3 ADP PEP complex was
determined in a similar way but the restrained individual
B-factor refinement was made. The final structure has
Rfree/Rcrys of 0.243/0.214 using a total of 4007 scatterers,
including solvent molecules, against all available 38,937
reflections in the resolution range of 30.0–2.25 Å. The
PFKFB3 ADP PEP structure contains a total of 449 amino
acid residues of the full length protein of 520 residues. For
both structures, more than 89% of the residues are in the
most favored region, 9.5% in the additional region, and the
rest in the generously allowed region in the Ramachandran plots. The structure refinement statistics are summarized in Table 1.
In all PFKFB3-related structures, K204, E380, C386,
V226, E330, and K79 are always in the generously allowed
region in the Ramachandran plots. Except for K79, all the
rest are very well defined by electron density in all
structures, although all are located in the loop regions. For
all PFKFB3 complex structures, the protein B-factor is
higher than that of the ligands. The reason is that all this
structures includes the N or C-terminal 28–45 residues
that are not connected to the core domains. Although their
electron density is defined well enough to assign the
structure, their B-factors are much higher than those of the
core regions. If only the core domains are counted, the
protein B-factors are lower than those of ligands.
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Protein Data Bank, accession codes
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The atomic coordinates and structure factors of the
PFKFB3 AMPPCP Fru-6-P complex (PDB accession code
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2DWP) and PFKFB3 ADP PEP complex (PDB accession
code 2DWO) have been deposited in the RCSB Protein
Data Bank.
10.
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